Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pancreatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Neoplasms 2Lung Neoplasms 2Head and Neck Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Rhabdoid Tumor 1Papillary renal cell carcinoma, sporadic 1Oropharyngeal Neoplasms 1Neoplasms, Squamous Cell 1Neoplasms, Basal Cell 1Multiple Myeloma 1Mouth Neoplasms 1Melanoma 1Lymphoma, Non-Hodgkin 1Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1Liver Cirrhosis 1Laryngeal Neoplasms 1Kidney Neoplasms 1Hypopharyngeal Neoplasms 1Hereditary leiomyomatosis and renal cell cancer 1Colonic Neoplasms 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms 1Adult Solid Neoplasm 1

Interventions

pembrolizumab 66Cisplatin 40Carboplatin 25Cetuximab 23Magnetic Resonance Spectroscopy 19Paclitaxel 18Nivolumab 17Specimen Handling 16Radiotherapy, Intensity-Modulated 16Radiotherapy 14Docetaxel 13Platinum 121,2-diaminocyclohexaneplatinum II citrate 11Fluorouracil 9Taxes 8Biopsy 8atezolizumab 6cemiplimab 5Surgical Procedures, Operative 5Radiation 5Ipilimumab 5(225)Ac-DOTA-c(RGDyK) 5dostarlimab 4Standard of Care 4Immunoglobulin G 4Immune Checkpoint Inhibitors 4Cyclophosphamide 4Bevacizumab 4Albumin-Bound Paclitaxel 4toripalimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Erlotinib Hydrochloride × 90 days × Clear all
NCT00076310 2026-04-15

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
50 enrolled 11 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡